References
- 1. Srivastava H, Reddy DS, Shah SN, Shah V. Castleman’s disease. J Oral Maxillofac Pathol. 2020;24:593. DOI: 10.4103/jomfp.JOMFP_283_20808344633967527
- 2. Castleman B, Towne VW. Case records of the Massachusetts General Hospital. Vol. 250. p. 1001-5. DOI: 10.1056/NEJM19540610250230813165944
- 3. Wu D, Lim MS, Jaffe ES. Pathology of Castleman disease. Hematology/Oncology Clinics. 2018;32:37-52. DOI: 10.1016/j.hoc.2017.09.00429157618
- 4. Casper C. The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care. Br J Haematol. 2005;129:3-17. DOI: 10.1111/j.1365-2141.2004.05311.x15801951
- 5. Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 1972;29:670-83. DOI: 10.1002/1097-0142(197203)29:3%3C670::AIDCNCR2820290321%3E3.0.CO;2-%23
- 6. Oksenhendler E, Boutboul D, Fajgenbaum D, Mirouse A, Fieschi C, Malphettes M, et al. The full spectrum of Castleman disease: 273 patients studied over 20 years. British Journal of Haematology. 2018;180:206-16. DOI: 10.1111/bjh.15019
- 7. Beckham TH, Yang JC, Chau KW, Noy A, Yahalom J. Excellent outcomes with surgery or radiotherapy in the management of Castleman disease including a case of oligocentric disease. Clinical Lymphoma Myeloma and Leukemia. 2020;20:685-9. DOI: 10.1016/j.clml.2020.05.002
- 8. Oksenhendler E, Boulanger E, Galicier L, Du MQ, Dupin N, Diss TC, et al. High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood. 2002;99:2331-6. DOI: 10.1182/blood.V99.7.2331
- 9. Glazer M, Rao VM, Reiter D, McCue P. Isolated Castleman disease of the neck: MR findings. AJNR Am J Neuroradiol. 1995;16:669-71.
- 10. Menke DM, Tiemann M, Camoriano JK, Chang SF, Madan A, Chow M, et al. Diagnosis of Castleman’s disease by identification of an immunophenotypically aberrant population of mantle zone B lymphocytes in paraffin-embedded lymph node biopsies. Am J Clin Pathol. 1996;105:268-76. DOI: 10.1093/ajcp/105.3.268
- 11. Wojtyś M, Piekarska A, Kunc M, Ptaszyński K, Biernat W, Zaucha JM, et al. Clinicopathological comparison and therapeutic approach to Castleman disease-a case-based review. J Thorac Dis. 2019;11:4859-74. DOI: 10.21037/jtd.2019.10.73
- 12. Falchi L, Capello D, Palumbo B, Rauco A, Emili R, Cianciulli M, et al. A case of nodular sclerosis Hodgkin’s lymphoma repeatedly relapsing in the context of composite plasma cell-hyaline vascular Castleman’s disease: successful response to rituximab and radiotherapy. Eur J Haematol. 2007;79:455-61. DOI: 10.1111/j.1600-0609.2007.00952.x212112517908180
- 13. El-Osta HE, Kurzrock R. Castleman’s disease: from basic mechanisms to molecular therapeutics. The Oncologist. 2011;16:497-511. DOI: 10.1634/theoncologist.2010-0212322812221441298
- 14. Nishi J, Arimura K, Utsunomiya A, Yonezawa S, Kawakami K, Maeno N, et al. Expression of vascular endothelial growth factor in sera and lymph nodes of the plasma cell type of Castleman’s disease. Br J Haematol. 1999;104:482-5. DOI: 10.1046/j.1365-2141.1999.01208.x10086783
- 15. Mohtaram A, Afif M, Sghiri T, Rami A, Latib R, Kettani F, et al. Coexistence of Hodgkin’s Lymphoma and Castleman’s Disease: A Case Report with Successful Response to Chemotherapy and Radiotherapy. Case Rep Oncol Med. 2013;2013. DOI: 10.1155/2013/487205387012924381772
- 16. Selvaraj K, Gudipudi D. Recurrent and Hodgkin’s lymphoma-associated multicentric Castleman’s disease in head and neck region. International Journal of Otorhinolaryngology and Head and Neck Surgery. 2020;6:1882. DOI: 10.18203/issn.2454-5929.ijohns20204193
- 17. Maheswaran PR, Ramsay AD, Norton AJ, Roche WR. Hodgkin’s disease presenting with the histological features of Castleman’s disease. Histopathology. 1991;18:249-53. DOI: 10.1111/j.1365-2559.1991.tb00833.x1675190
- 18. Zarate-Osorno A, Medeiros LJ, Danon AD, Neiman RS. Hodgkin’s disease with coexistent Castleman-like histologic features. A report of three cases. Arch Pathol Lab Med. 1994;118:270-4.
- 19. Gong S, Hijiya N. Classical Hodgkin lymphoma and Castleman disease: a rare morphologic combination. Blood, The Journal of the American Society of Hematology. 2017;130:381. DOI: 10.1182/blood-2017-05-78212828729340
- 20. Yu L, Tu M, Cortes J, Xu-Monette ZY, Miranda RN, Zhang J, et al. Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman disease. Blood. 2017;129:1658-68. DOI: 10.1182/blood-2016-11-748855536434328100459